APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acyclovir

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Acyclovir Industry Growth and Trends Forecast to 2032

19 December 202590 pages

Choose your research edition.

Industry ResearchAcyclovir Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Acyclovir Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Acyclovir Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acyclovir Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Acyclovir Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Acyclovir market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Acyclovir is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Acyclovir is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Acyclovir is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Acyclovir include GSK, TEVA, Mylan, Fresenius Kabi, Zydus Pharmaceuticals, Vectans Pharma (Onxeo), Bausch Health and APOTEX, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Acyclovir market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Acyclovir market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acyclovir market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acyclovir.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Acyclovir market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Acyclovir Market by Company

GSK

TEVA

Mylan

Fresenius Kabi

Zydus Pharmaceuticals

Vectans Pharma (Onxeo)

Bausch Health

APOTEX

Acyclovir Segment by Type

Oral Product

Injection Product

Acyclovir Segment by Application

Hospitals

Clinics

Others

Acyclovir Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acyclovir market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acyclovir and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acyclovir.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Acyclovir manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Acyclovir in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Product Table 2. Major Company of Injection Product Table 3. Global Acyclovir Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Acyclovir Sales by Type (2021-2026) & (K Units) Table 5. Global Acyclovir Sales Market Share in Volume by Type (2021-2026) Table 6. Global Acyclovir Sales by Type (2021-2026) & (US$ Million) Table 7. Global Acyclovir Sales Market Share in Value by Type (2021-2026) Table 8. Global Acyclovir Price by Type (2021-2026) & (US$/Unit) Table 9. Global Acyclovir Sales by Type (2027-2032) & (K Units) Table 10. Global Acyclovir Sales Market Share in Volume by Type (2027-2032) Table 11. Global Acyclovir Sales by Type (2027-2032) & (US$ Million) Table 12. Global Acyclovir Sales Market Share in Value by Type (2027-2032) Table 13. Global Acyclovir Price by Type (2027-2032) & (US$/Unit) Table 14. North America Acyclovir Sales by Type (2021-2026) & (K Units) Table 15. North America Acyclovir Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Acyclovir Sales by Type (2021-2026) & (K Units) Table 17. Europe Acyclovir Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Acyclovir Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Acyclovir Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Acyclovir Sales by Type (2021-2026) & (K Units) Table 21. Latin America Acyclovir Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Acyclovir Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Acyclovir Sales by Type (2021-2026) & (US$ Million) Table 24. Acyclovir Industry Trends Table 25. Acyclovir Industry Drivers Table 26. Acyclovir Industry Opportunities and Challenges Table 27. Acyclovir Industry Restraints Table 28. Global Acyclovir Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Acyclovir Revenue Market Share by Company (2021-2026) Table 30. Global Acyclovir Sales by Company (2021-2026) & (K Units) Table 31. Global Acyclovir Sales Share by Company (2021-2026) Table 32. Global Acyclovir Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Acyclovir Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Acyclovir Major Company Production Sites and Headquarters Table 35. Global Acyclovir Company, Product Type & Application Table 36. Global Acyclovir Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Acyclovir by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Acyclovir Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Acyclovir Sales by Region (2021-2026) & (K Units) Table 41. Global Acyclovir Sales Market Share in Volume by Region (2021-2026) Table 42. Global Acyclovir Sales by Region (2021-2026) & (US$ Million) Table 43. Global Acyclovir Sales Market Share in Value by Region (2021-2026) Table 44. Global Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Acyclovir Sales by Region (2027-2032) & (K Units) Table 46. Global Acyclovir Sales Market Share in Volume by Region (2027-2032) Table 47. Global Acyclovir Sales by Region (2027-2032) & (US$ Million) Table 48. Global Acyclovir Sales Market Share in Value by Region (2027-2032) Table 49. Global Acyclovir Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Acyclovir Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Acyclovir Sales by Application (2021-2026) & (K Units) Table 52. Global Acyclovir Sales Market Share in Volume by Application (2021-2026) Table 53. Global Acyclovir Sales by Application (2021-2026) & (US$ Million) Table 54. Global Acyclovir Sales Market Share in Value by Application (2021-2026) Table 55. Global Acyclovir Price by Application (2021-2026) & (US$/Unit) Table 56. Global Acyclovir Sales by Application (2027-2032) & (K Units) Table 57. Global Acyclovir Sales Market Share in Volume by Application (2027-2032) Table 58. Global Acyclovir Sales by Application (2027-2032) & (US$ Million) Table 59. Global Acyclovir Sales Market Share in Value by Application (2027-2032) Table 60. Global Acyclovir Price by Application (2027-2032) & (US$/Unit) Table 61. North America Acyclovir Sales by Application (2021-2026) & (K Units) Table 62. North America Acyclovir Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Acyclovir Sales by Application (2021-2026) & (K Units) Table 64. Europe Acyclovir Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Acyclovir Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Acyclovir Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Acyclovir Sales by Application (2021-2026) & (K Units) Table 68. Latin America Acyclovir Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Acyclovir Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Acyclovir Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. GSK Acyclovir Product Portfolio Table 75. GSK Recent Development Table 76. TEVA Company Information Table 77. TEVA Business Overview Table 78. TEVA Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. TEVA Acyclovir Product Portfolio Table 80. TEVA Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Mylan Acyclovir Product Portfolio Table 85. Mylan Recent Development Table 86. Fresenius Kabi Company Information Table 87. Fresenius Kabi Business Overview Table 88. Fresenius Kabi Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Fresenius Kabi Acyclovir Product Portfolio Table 90. Fresenius Kabi Recent Development Table 91. Zydus Pharmaceuticals Company Information Table 92. Zydus Pharmaceuticals Business Overview Table 93. Zydus Pharmaceuticals Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Zydus Pharmaceuticals Acyclovir Product Portfolio Table 95. Zydus Pharmaceuticals Recent Development Table 96. Vectans Pharma (Onxeo) Company Information Table 97. Vectans Pharma (Onxeo) Business Overview Table 98. Vectans Pharma (Onxeo) Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Vectans Pharma (Onxeo) Acyclovir Product Portfolio Table 100. Vectans Pharma (Onxeo) Recent Development Table 101. Bausch Health Company Information Table 102. Bausch Health Business Overview Table 103. Bausch Health Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Bausch Health Acyclovir Product Portfolio Table 105. Bausch Health Recent Development Table 106. APOTEX Company Information Table 107. APOTEX Business Overview Table 108. APOTEX Acyclovir Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. APOTEX Acyclovir Product Portfolio Table 110. APOTEX Recent Development Table 111. North America Acyclovir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Acyclovir Sales by Country (2021-2026) & (K Units) Table 113. North America Acyclovir Sales Market Share by Country (2021-2026) Table 114. North America Acyclovir Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Acyclovir Sales Market Share Forecast by Country (2027-2032) Table 116. North America Acyclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Acyclovir Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Acyclovir Market Share by Country (2021-2026) Table 119. North America Acyclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Acyclovir Market Share Forecast by Country (2027-2032) Table 121. Europe Acyclovir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Acyclovir Sales by Country (2021-2026) & (K Units) Table 123. Europe Acyclovir Sales Market Share by Country (2021-2026) Table 124. Europe Acyclovir Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Acyclovir Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Acyclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Acyclovir Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Acyclovir Market Share by Country (2021-2026) Table 129. Europe Acyclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Acyclovir Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Acyclovir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Acyclovir Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Acyclovir Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Acyclovir Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Acyclovir Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Acyclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Acyclovir Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Acyclovir Market Share by Country (2021-2026) Table 139. Asia-Pacific Acyclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Acyclovir Market Share Forecast by Country (2027-2032) Table 141. Latin America Acyclovir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Acyclovir Sales by Country (2021-2026) & (K Units) Table 143. Latin America Acyclovir Sales Market Share by Country (2021-2026) Table 144. Latin America Acyclovir Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Acyclovir Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Acyclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Acyclovir Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Acyclovir Market Share by Country (2021-2026) Table 149. Latin America Acyclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Acyclovir Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Acyclovir Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Acyclovir Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Acyclovir Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Acyclovir Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Acyclovir Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Acyclovir Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Acyclovir Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Acyclovir Market Share by Country (2021-2026) Table 159. Middle East and Africa Acyclovir Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Acyclovir Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Acyclovir Distributors List Table 164. Acyclovir Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Acyclovir Image Figure 2. Global Acyclovir Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acyclovir Market Size (2021-2032) & (US$ Million) Figure 4. Global Acyclovir Sales (2021-2032) & (K Units) Figure 5. Oral Product Image Figure 6. Global Oral Product Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Product Image Figure 8. Global Injection Product Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Acyclovir Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Acyclovir Market Share by Type 2025 VS 2032 Figure 11. North America Acyclovir Sales Market Share in Volume by Type in 2025 Figure 12. North America Acyclovir Sales Market Share in Value by Type in 2025 Figure 13. Europe Acyclovir Sales Market Share in Volume by Type in 2025 Figure 14. Europe Acyclovir Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Acyclovir Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Acyclovir Sales Market Share in Value by Type in 2025 Figure 17. Latin America Acyclovir Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Acyclovir Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Acyclovir Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Acyclovir Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Acyclovir Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospitals Image Figure 24. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinics Image Figure 26. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Acyclovir Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Acyclovir Market Share by Application 2025 VS 2032 Figure 31. North America Acyclovir Sales Market Share in Volume by Application in 2025 Figure 32. North America Acyclovir Sales Market Share in Value by Application in 2025 Figure 33. Europe Acyclovir Sales Market Share in Volume by Application in 2025 Figure 34. Europe Acyclovir Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Acyclovir Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Acyclovir Sales Market Share in Value by Application in 2025 Figure 37. Latin America Acyclovir Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Acyclovir Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Acyclovir Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Acyclovir Sales Market Share in Value by Application in 2025 Figure 41. North America Acyclovir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Acyclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Acyclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Acyclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Acyclovir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Acyclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Acyclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Acyclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Acyclovir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Acyclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Acyclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Acyclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Acyclovir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Acyclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Acyclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Acyclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Acyclovir Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Acyclovir Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Acyclovir Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Acyclovir Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Acyclovir Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Acyclovir Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Product
  • Injection Product
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • GSK
  • TEVA
  • Mylan
  • Fresenius Kabi
  • Zydus Pharmaceuticals
  • Vectans Pharma (Onxeo)
  • Bausch Health
  • APOTEX

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Acyclovir Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Acyclovir Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Acyclovir Market by Type
  6. 1.3.1 Oral Product
  7. 1.3.2 Injection Product
  8. 1.4 Global Acyclovir Market Size by Type
  9. 1.4.1 Global Acyclovir Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Acyclovir Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Acyclovir Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Acyclovir Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Acyclovir Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Acyclovir Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Acyclovir Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Acyclovir Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Acyclovir Industry Trends
  2. 2.2 Acyclovir Industry Drivers
  3. 2.3 Acyclovir Industry Opportunities and Challenges
  4. 2.4 Acyclovir Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Acyclovir Revenue (2021-2026)
  2. 3.2 Global Top Players by Acyclovir Sales (2021-2026)
  3. 3.3 Global Top Players by Acyclovir Price (2021-2026)
  4. 3.4 Global Acyclovir Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Acyclovir Major Company Production Sites & Headquarters
  6. 3.6 Global Acyclovir Company, Product Type & Application
  7. 3.7 Global Acyclovir Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Acyclovir Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Acyclovir Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Acyclovir Tier 1, Tier 2, and Tier 3
4 Acyclovir Regional Status and Outlook
  1. 4.1 Global Acyclovir Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Acyclovir Historic Market Size by Region
  3. 4.2.1 Global Acyclovir Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Acyclovir Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Acyclovir Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Acyclovir Forecasted Market Size by Region
  7. 4.3.1 Global Acyclovir Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Acyclovir Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Acyclovir Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acyclovir by Application
  1. 5.1 Acyclovir Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Acyclovir Market Size by Application
  6. 5.2.1 Global Acyclovir Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Acyclovir Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Acyclovir Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Acyclovir Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Acyclovir Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Acyclovir Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Acyclovir Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Acyclovir Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Acyclovir Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 TEVA
  8. 6.2.1 TEVA Company Information
  9. 6.2.2 TEVA Business Overview
  10. 6.2.3 TEVA Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 TEVA Acyclovir Product Portfolio
  12. 6.2.5 TEVA Recent Developments
  13. 6.3 Mylan
  14. 6.3.1 Mylan Company Information
  15. 6.3.2 Mylan Business Overview
  16. 6.3.3 Mylan Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan Acyclovir Product Portfolio
  18. 6.3.5 Mylan Recent Developments
  19. 6.4 Fresenius Kabi
  20. 6.4.1 Fresenius Kabi Company Information
  21. 6.4.2 Fresenius Kabi Business Overview
  22. 6.4.3 Fresenius Kabi Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Fresenius Kabi Acyclovir Product Portfolio
  24. 6.4.5 Fresenius Kabi Recent Developments
  25. 6.5 Zydus Pharmaceuticals
  26. 6.5.1 Zydus Pharmaceuticals Company Information
  27. 6.5.2 Zydus Pharmaceuticals Business Overview
  28. 6.5.3 Zydus Pharmaceuticals Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zydus Pharmaceuticals Acyclovir Product Portfolio
  30. 6.5.5 Zydus Pharmaceuticals Recent Developments
  31. 6.6 Vectans Pharma (Onxeo)
  32. 6.6.1 Vectans Pharma (Onxeo) Company Information
  33. 6.6.2 Vectans Pharma (Onxeo) Business Overview
  34. 6.6.3 Vectans Pharma (Onxeo) Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Vectans Pharma (Onxeo) Acyclovir Product Portfolio
  36. 6.6.5 Vectans Pharma (Onxeo) Recent Developments
  37. 6.7 Bausch Health
  38. 6.7.1 Bausch Health Company Information
  39. 6.7.2 Bausch Health Business Overview
  40. 6.7.3 Bausch Health Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bausch Health Acyclovir Product Portfolio
  42. 6.7.5 Bausch Health Recent Developments
  43. 6.8 APOTEX
  44. 6.8.1 APOTEX Company Information
  45. 6.8.2 APOTEX Business Overview
  46. 6.8.3 APOTEX Acyclovir Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 APOTEX Acyclovir Product Portfolio
  48. 6.8.5 APOTEX Recent Developments
7 North America by Country
  1. 7.1 North America Acyclovir Sales by Country
  2. 7.1.1 North America Acyclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Acyclovir Sales by Country (2021-2026)
  4. 7.1.3 North America Acyclovir Sales Forecast by Country (2027-2032)
  5. 7.2 North America Acyclovir Market Size by Country
  6. 7.2.1 North America Acyclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Acyclovir Market Size by Country (2021-2026)
  8. 7.2.3 North America Acyclovir Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Acyclovir Sales by Country
  2. 8.1.1 Europe Acyclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Acyclovir Sales by Country (2021-2026)
  4. 8.1.3 Europe Acyclovir Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Acyclovir Market Size by Country
  6. 8.2.1 Europe Acyclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Acyclovir Market Size by Country (2021-2026)
  8. 8.2.3 Europe Acyclovir Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Acyclovir Sales by Country
  2. 9.1.1 Asia-Pacific Acyclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Acyclovir Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Acyclovir Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Acyclovir Market Size by Country
  6. 9.2.1 Asia-Pacific Acyclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Acyclovir Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Acyclovir Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Acyclovir Sales by Country
  2. 10.1.1 South America Acyclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Acyclovir Sales by Country (2021-2026)
  4. 10.1.3 South America Acyclovir Sales Forecast by Country (2027-2032)
  5. 10.2 South America Acyclovir Market Size by Country
  6. 10.2.1 South America Acyclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Acyclovir Market Size by Country (2021-2026)
  8. 10.2.3 South America Acyclovir Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Acyclovir Sales by Country
  2. 11.1.1 Middle East and Africa Acyclovir Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Acyclovir Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Acyclovir Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Acyclovir Market Size by Country
  6. 11.2.1 Middle East and Africa Acyclovir Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Acyclovir Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Acyclovir Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Acyclovir Value Chain Analysis
  2. 12.1.1 Acyclovir Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Acyclovir Production Mode & Process
  7. 12.2 Acyclovir Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Acyclovir Distributors
  10. 12.2.3 Acyclovir Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst